- Report
- August 2023
- 70 Pages
Europe
From €4519EUR$4,750USD£3,870GBP
- Report
- August 2023
- 112 Pages
North America
From €4519EUR$4,750USD£3,870GBP
- Report
- August 2023
- 90 Pages
North America
From €4519EUR$4,750USD£3,870GBP
- Report
- August 2023
- 70 Pages
Latin America
From €4519EUR$4,750USD£3,870GBP
- Report
- December 2023
- 97 Pages
Middle East, Africa
From €2364EUR$2,485USD£2,024GBP
€3378EUR$3,550USD£2,892GBP
- Report
- December 2023
- 112 Pages
Europe
From €2364EUR$2,485USD£2,024GBP
€3378EUR$3,550USD£2,892GBP
- Report
- December 2023
- 107 Pages
Asia Pacific
From €2364EUR$2,485USD£2,024GBP
€3378EUR$3,550USD£2,892GBP
- Report
- December 2023
- 99 Pages
North America
From €2364EUR$2,485USD£2,024GBP
€3378EUR$3,550USD£2,892GBP
- Report
- November 2023
- 147 Pages
Asia Pacific
From €1427EUR$1,500USD£1,222GBP
- Report
- November 2023
- 146 Pages
Middle East, Africa
From €1427EUR$1,500USD£1,222GBP
- Report
- June 2023
- 98 Pages
Asia Pacific
From €1427EUR$1,500USD£1,222GBP
- Report
- June 2023
- 88 Pages
North America
From €1427EUR$1,500USD£1,222GBP
- Report
- June 2023
- 97 Pages
Middle East, Africa
From €1427EUR$1,500USD£1,222GBP
- Report
- June 2023
- 97 Pages
Europe
From €1427EUR$1,500USD£1,222GBP
- Report
- August 2023
- 300 Pages
Middle East, Africa
From €4662EUR$4,900USD£3,992GBP
- Report
- August 2023
- 300 Pages
Latin America
From €4662EUR$4,900USD£3,992GBP
- Report
- August 2023
- 300 Pages
Asia Pacific
From €4662EUR$4,900USD£3,992GBP
- Report
- August 2023
- 300 Pages
Europe
From €4662EUR$4,900USD£3,992GBP
- Report
- November 2023
- 122 Pages
Europe
From €3283EUR$3,450USD£2,811GBP
- Report
- November 2023
- 119 Pages
North America
From €2807EUR$2,950USD£2,403GBP
The Type 2 diabetes market, within the context of diabetes devices, encompasses a range of products designed to monitor and control blood glucose levels, as well as deliver insulin for patients in need of external sources of the hormone. Key devices include blood glucose meters, continuous glucose monitoring (CGM) systems, insulin pumps, and smart insulin pens. These devices are essential for patients to manage their condition effectively, helping to reduce the risk of complications associated with diabetes and improving overall quality of life. Advances in technology have led to the development of more accurate, user-friendly, and integrated devices, many of which can connect to smartphone apps and health management platforms to assist in tracking and analyzing diabetic data over time. This integration facilitates better personalized care and more refined treatment plans.
Companies active in the Type 2 diabetes devices market comprise a mix of established pharmaceutical companies and specialized medical device manufacturers. Some notable companies include Medtronic, Abbott Laboratories, Dexcom, Inc., Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care, LifeScan, Inc., and Roche Diabetes Care. These companies are at the forefront of innovation in the diabetes devices sector, investing in research and development to offer advanced solutions that address the needs of those managing Type 2 diabetes. Show Less Read more